New drug shows promise for brain fog in Parkinson's
NCT ID NCT04476017
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 29 times
Summary
This study tested a new medicine called SAGE-718 in 18 people with Parkinson's disease who also have mild memory or thinking problems. The main goal was to see if the drug is safe and tolerable, and to check if it helps with thinking, mood, and movement. The study was completed and focused on safety, not on proving the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Long Beach, California, 90806, United States
-
Sage Investigational Site
Port Charlotte, Florida, 33980, United States
-
Sage Investigational Site
West Palm Beach, Florida, 33407, United States
-
Sage Investigational Site
Chicago, Illinois, 60612, United States
Conditions
Explore the condition pages connected to this study.